SUMO: A (Oxidative) Stressed Protein

NeuroMolecular Medicine

Volumn 15, Issue 4, 2013, Pages 707-719

  Feligioni, Marco ^a   Nisticò, Robert ^b,c  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

JNK; Neurodegeneration; Oxidative stress; Posttranslational modification; SUMOylation

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; SUMO PROTEIN;

DIABETES MELLITUS; MOLECULAR PATHOLOGY; NEOPLASM; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SUMOYLATION;

ANIMALS; DIABETES MELLITUS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; NEOPLASM PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 84888169173     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-013-8266-6     Document Type: Review

References (112)

1. Anderson, D. B.; Wilkinson, K. A.; Henley, J. M. (2009). Protein SUMOylation in neuropathological conditions. Drug news and perspectives, 22(5), 255-265.
2. Armogida, M.; Nisticò, R.; Mercuri, N. B. (2012). Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. British Journal of Pharmacology, 166(4), 1211-1224.
3. Behrens, A.; Sibilia, M.; Wagner, E. F. (1999). Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nature Genetics, 21(3), 326-329.
4. Boggio, R.; Colombo, R.; Hay, R. T.; Draetta, G. F.; Chiocca, S. (2004). A mechanism for inhibiting the SUMO pathway. Molecular Cell, 16(4), 549-561.
5. Bohren, K. M.; Nadkarni, V.; Song, J. H.; Gabbay, K. H.; Owerbach, D. (2004). A M55 V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. The Journal of biological chemistry, 279(26), 27233-27238.
6. Bononi, A.; Agnoletto, C.; De Marchi, E.; Marchi, S.; Patergnani, S.; Bonora, M.; et al. (2011). Protein kinases and phosphatases in the control of cell fate. Enzyme research, 2011, 329098.
7. Borsello, T.; Clarke, P. G. H.; Hirt, L.; Vercelli, A.; Repici, M.; Schorderet, D. F.; et al. (2003). A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nature Medicine, 9(9), 1180-1186.
8. Bossis, G.; Malnou, C. E.; Farras, R.; Andermarcher, E.; Hipskind, R.; Rodriguez, M.; et al. (2005). Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Molecular and Cellular Biology, 25(16), 6964-6979.
9. Bossis, G.; Melchior, F. (2006a). SUMO: Regulating the regulator. Cell division, 1, 13.
10. Bossis, G.; Melchior, F. (2006b). Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Molecular Cell, 21(3), 349-357.
11. Cadenas, E.; Davies, K. J. (2000). Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biology and Medicine, 29(3-4), 222-230.
12. Choi, S. J.; Chung, S. S.; Rho, E. J.; Lee, H. W.; Lee, M. H.; Choi, H.-S.; et al. (2006). Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. The Journal of biological chemistry, 281(41), 30669-30677.
13. Choi, W.-S.; Klintworth, H. M.; Xia, Z. (2011). JNK3-mediated apoptotic cell death in primary dopaminergic neurons. Methods in molecular biology (Clifton, NJ), 758, 279-292.
14. Ciechanover, A.; Elias, S.; Heller, H.; Ferber, S.; Hershko, A. (1980). Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes. The Journal of biological chemistry, 255(16), 7525-7528.
15. Dadke, S.; Cotteret, S.; Yip, S.-C.; Jaffer, Z. M.; Haj, F.; Ivanov, A.; et al. (2007). Regulation of protein tyrosine phosphatase 1B by sumoylation. Nature Cell Biology, 9(1), 80-85.
16. Dangoumau, A.; Veyrat-Durebex, C.; Blasco, H.; Praline, J.; Corcia, P.; Andres, C. R.; et al. (2013). Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. The International journal of neuroscience, 123(6), 366-374.
17. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell, 103(2), 239-252.
18. De la Vega, L.; Grishina, I.; Moreno, R.; Krüger, M.; Braun, T.; Schmitz, M. L. (2012). A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Molecular Cell, 46(4), 472-483.
19. Desterro, J. M.; Rodriguez, M. S.; Hay, R. T. (1998). SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Molecular Cell, 2(2), 233-239.
20. Devasagayam, T. P. A.; Tilak, J. C.; Boloor, K. K.; Sane, K. S.; Ghaskadbi, S. S.; Lele, R. D. (2004). Free radicals and antioxidants in human health: current status and future prospects. The Journal of the Association of Physicians of India, 52, 794-804.
21. Dorval, V.; Fraser, P. E. (2006). Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. The Journal of biological chemistry, 281(15), 9919-9924.
22. Dorval, V.; Mazzella, M. J.; Mathews, P. M.; Hay, R. T.; Fraser, P. E. (2007). Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. The Biochemical Journal, 404(2), 309-316.
23. Elsasser, S.; Gali, R. R.; Schwickart, M.; Larsen, C. N.; Leggett, D. S.; Müller, B.; et al. (2002). Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nature Cell Biology, 4(9), 725-730.
24. Fei, E.; Jia, N.; Yan, M.; Ying, Z.; Sun, Q.; Wang, H.; et al. (2006). SUMO-1 modification increases human SOD1 stability and aggregation. Biochemical and Biophysical Research Communications, 347(2), 406-412.
25. Feligioni, M.; Brambilla, E.; Camassa, A.; Sclip, A.; Arnaboldi, A.; Morelli, F.; et al. (2011). Crosstalk between JNK and SUMO Signaling Pathways: deSUMOylation Is Protective against H(2)O(2)-Induced Cell Injury. PLoS ONE, 6(12), e28185.
26. Foran, E.; Bogush, A.; Goffredo, M.; Roncaglia, P.; Gustincich, S.; Pasinelli, P.; et al. (2011). Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia, 59(11), 1719-1731.
27. Gareau, J. R.; Lima, C. D. (2010). The SUMO pathway: Emerging mechanisms that shape specificity, conjugation and recognition. Nature Reviews Molecular Cell Biology, 11(12), 861-871.
28. Gibb, S. L.; Boston-Howes, W.; Lavina, Z. S.; Gustincich, S.; Brown, R. H.; Pasinelli, P.; et al. (2007). A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. The Journal of biological chemistry, 282(44), 32480-32490.
29. Giorgino, F.; de Robertis, O.; Laviola, L.; Montrone, C.; Perrini, S.; McCowen, K. C.; et al. (2000). The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proceedings of the National Academy of Sciences of the United States of America, 97(3), 1125-1130.
30. Gius, D.; Botero, A.; Shah, S.; Curry, H. A. (1999). Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicology Letters, 106(2-3), 93-106.
31. Guo, D.; Han, J.; Adam, B.-L.; Colburn, N. H.; Wang, M.-H.; Dong, Z.; et al. (2005). Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochemical and Biophysical Research Communications, 337(4), 1308-1318.
32. Guo, D.; Li, M.; Zhang, Y.; Yang, P.; Eckenrode, S.; Hopkins, D.; et al. (2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics, 36(8), 837-841.
33. Henchcliffe, C.; Beal, M. F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice. Neurology, 4(11), 600-609.
34. Hernández, F.; Gómez de Barreda, E.; Fuster-Matanzo, A.; Lucas, J. J.; Avila, J. (2010). GSK3: A possible link between beta amyloid peptide and tau protein. Experimental Neurology, 223(2), 322-325.
35. Hershko, A.; Ciechanover, A. (1998). The ubiquitin system. Annual Review of Biochemistry, 67, 425-479.
36. Hershko, A.; Heller, H.; Elias, S.; Ciechanover, A. (1983). Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. The Journal of biological chemistry, 258(13), 8206-8214.
37. Hochstrasser, M. (2000a). Biochemistry. All in the ubiquitin family. Science (New York, NY), 289(5479), 563-564.
38. Hochstrasser, M. (2000b). Evolution and function of ubiquitin-like protein-conjugation systems. Nature Cell Biology, 2(8), E153-E157.
39. Hochstrasser, Mark. (2009). Origin and function of ubiquitin-like proteins. Nature, 458(7237), 422-429.
40. Huang, J.; Berger, S. L. (2008). The emerging field of dynamic lysine methylation of non-histone proteins. Current Opinion in Genetics and Development, 18(2), 152-158.
41. Huang, H.; Du, G.; Chen, H.; Liang, X.; Li, C.; Zhu, N.; et al. (2011). Drosophila Smt3 negatively regulates JNK signaling through sequestering Hipk in the nucleus. Development(Cambridge, England), 138(12), 2477-2485.
42. Huang, E. J.; Reichardt, L. F. (2003). Trk receptors: Roles in neuronal signal transduction. Annual Review of Biochemistry, 72, 609-642.
43. Kerscher, O.; Felberbaum, R.; Hochstrasser, M. (2006). Modification of proteins by ubiquitin and ubiquitin-like proteins. Annual Review of Cell and Developmental Biology, 22, 159-180.
44. Kharb, S.; Singh, V.; Ghalaut, P. S.; Singh, G. P. (2000). Oxidative stress after acute myocardial infarction: Effect of thrombolytic treatment. The Journal of the Association of Physicians of India, 48(6), 578-580.
45. Krumova, P.; Meulmeester, E.; Garrido, M.; Tirard, M.; Hsiao, H-. H.; Bossis, G.; et al. (2011). Sumoylation inhibits alpha-synuclein aggregation and toxicity. The Journal of cell biology, 194(1), 49-60.
46. Krumova, P.; Weishaupt, J. H. (2013). Sumoylation in neurodegenerative diseases. Cellular and molecular life sciences: CMLS, 70(12), 2123-2138.
47. Kuan, C. Y.; Yang, D. D.; Samanta Roy, D. R.; Davis, R. J.; Rakic, P.; Flavell, R. A. (1999). The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 22(4), 667-676.
48. Kyriakis, J. M.; Banerjee, P.; Nikolakaki, E.; Dai, T.; Rubie, E. A.; Ahmad, M. F.; et al. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369(6476), 156-160.
49. La Rosa, L. R.; Matrone, C.; Ferraina, C.; Panico, M. B.; Piccirilli, S.; Di Certo, M. G.; et al. (2013). Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR. Journal of Alzheimer's disease: JAD, 33(1), 265-272.
50. Lalioti, V. S.; Vergarajauregui, S.; Pulido, D.; Sandoval, I. V. (2002). The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1. The Journal of biological chemistry, 277(22), 19783-19791.
51. Lambeth, J. D. (2004). NOX enzymes and the biology of reactive oxygen. Nature Reviews Immunology, 4(3), 181-189.
52. Lee, Y.-S.; Jang, M.-S.; Lee, J.-S.; Choi, E.-J.; Kim, E. (2005). SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Reports, 6(10), 949-955.
53. Leitao, B. B.; Jones, M. C.; Brosens, J. J. (2011). The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death. The FASEB journal: Official Publication of the Federation of American Societies for Experimental Biology, 25(10), 3416-3425.
54. Li, M.; Guo, D.; Isales, C. M.; Eizirik, D. L.; Atkinson, M.; She, J.-X.; et al. (2005). SUMO wrestling with type 1 diabetes. Journal of molecular medicine (Berlin, Germany), 83(7), 504-513.
55. Li, T.; Huang, S.; Dong, M.; Gui, Y.; Wu, D. (2012). Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy. Urologic Oncology. doi: 10.1016/j.urolonc.2012.03.007.
56. Li, X.; Luo, Y.; Yu, L.; Lin, Y.; Luo, D.; Zhang, H.; et al. (2008). SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis. Cell Death and Differentiation, 15(4), 739-750.
57. Liochev, S. I. (2013). Reactive oxygen species and the free radical theory of aging. Free Radical Biology and Medicine, 60, 1-4.
58. Ma, Q.-L.; Yang, F.; Rosario, E. R.; Ubeda, O. J.; Beech, W.; Gant, D. J.; et al. (2009). Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. The Journal of neuroscience: The Official Journal of the Society for Neuroscience, 29(28), 9078-9089.
59. Mahajan, R.; Delphin, C.; Guan, T.; Gerace, L.; Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88(1), 97-107.
60. Manza, L. L.; Codreanu, S. G.; Stamer, S. L.; Smith, D. L.; Wells, K. S.; Roberts, R. L.; et al. (2004). Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chemical Research in Toxicology, 17(12), 1706-1715.
61. Markesbery, W. R. (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology and Medicine, 23(1), 134-147.
62. Matunis, M. J.; Coutavas, E.; Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. The Journal of cell biology, 135(6 Pt 1), 1457-1470.
63. May, J. M.; de Haën, C. (1979). Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. The Journal of biological chemistry, 254(7), 2214-2220.
64. McDoniels-Silvers, A. L.; Nimri, C. F.; Stoner, G. D.; Lubet, R. A.; You, M. (2002). Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clinical cancer research: An Official Journal of the American Association for Cancer Research, 8(4), 1127-1138.
65. McLennan, Y.; Polussa, J.; Tassone, F.; Hagerman, R. (2011). Fragile x syndrome. Current Genomics, 12(3), 216-224.
66. Melchior, F. (2000). SUMO-nonclassical ubiquitin. Annual Review of Cell and Developmental Biology, 16, 591-626.
67. Minty, A.; Dumont, X.; Kaghad, M.; Caput, D. (2000). Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. The Journal of Biological Chemistry, 275(46), 36316-36323.
68. Moore, D. J.; Zhang, L.; Dawson, T. M.; Dawson, V. L. (2003). A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. Journal of Neurochemistry, 87(6), 1558-1567.
69. Muller, S.; Berger, M.; Lehembre, F.; Seeler, J. S.; Haupt, Y.; Dejean, A. (2000). c-Jun and p53 activity is modulated by SUMO-1 modification. The Journal of Biological Chemistry, 275(18), 13321-13329.
70. Navascués, J.; Bengoechea, R.; Tapia, O.; Vaqué, J. P.; Lafarga, M.; Berciano, M. T. (2007). Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells. Chromosoma, 116(5), 441-451.
71. Nisticò, R.; Piccirilli, S.; Cucchiaroni, M. L.; Armogida, M.; Guatteo, E.; Giampà, C.; et al. (2008). Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. British Journal of Pharmacology, 153(5), 1022-1029.
72. Ogata, M.; Hino, S.; Saito, A.; Morikawa, K.; Kondo, S.; Kanemoto, S.; et al. (2006). Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology, 26(24), 9220-9231.
73. Okura, T.; Gong, L.; Kamitani, T.; Wada, T.; Okura, I.; Wei, C. F.; et al. (1996). Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. The Journal of Immunology, 157(10), 4277-4281.
74. Olzmann, J. A.; Brown, K.; Wilkinson, K. D.; Rees, H. D.; Huai, Q.; Ke, H.; et al. (2004). Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. The Journal of Biological Chemistry, 279(9), 8506-8515.
75. Patel, V. P.; Chu, C. T. (2011). Nuclear transport, oxidative stress, and neurodegeneration. International Journal of Clinical and Experimental Pathology, 4(3), 215-229.
76. Ploia, C.; Antoniou, X.; Sclip, A.; Grande, V.; Cardinetti, D.; Colombo, A.; et al. (2011). JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models. Journal of Alzheimer's Disease: JAD, 26(2), 315-329.
77. Pulverer, B. J.; Kyriakis, J. M.; Avruch, J.; Nikolakaki, E.; Woodgett, J. R. (1991). Phosphorylation of c-jun mediated by MAP kinases. Nature, 353(6345), 670-674.
78. Rhee, S. G.; Kang, S. W.; Jeong, W.; Chang, T.-S.; Yang, K.-S.; Woo, H. A. (2005). Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Current Opinion in Cell Biology, 17(2), 183-189.
79. Rodriguez, M. S.; Dargemont, C.; Hay, R. T. (2001). SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. The Journal of Biological Chemistry, 276(16), 12654-12659.
80. Rui, H.-L.; Fan, E.; Zhou, H.-M.; Xu, Z.; Zhang, Y.; Lin, S.-C. (2002). SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. The Journal of Biological Chemistry, 277(45), 42981-42986.
81. Ruipérez, V.; Darios, F.; Davletov, B. (2010). Alpha-synuclein, lipids and Parkinson's disease. Progress in Lipid Research, 49(4), 420-428.
82. Ryu, J.; Cho, S.; Park, B. C.; Lee, D. H. (2010). Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: Implication of JNK pathway. Biochemical and Biophysical Research Communications, 393(2), 280-285.
83. Schneider Aguirre, R.; Karpen, S. J. (2013). Inflammatory Mediators Increase SUMOylation of RXRα in a JNK-Dependent Manner in Human Hepatocellular Carcinoma Cells. Molecular Pharmacology, 84(2), 218-226.
84. Sclip, A.; Antoniou, X.; Colombo, A.; Camici, G. G.; Pozzi, L.; Cardinetti, D.; et al. (2011). c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model. The Journal of Biological Chemistry, 286(51), 43871-43880.
85. Shchemelinin, I.; Sefc, L.; Necas, E. (2006). Protein kinases, their function and implication in cancer and other diseases. Folia Biologica, 52(3), 81-100.
86. Shin, J.; Yu, S.-B.; Yu, U. Y.; Jo, S. A.; Ahn, J.-H. (2010). Swedish mutation within amyloid precursor protein modulates global gene expression towards the pathogenesis of Alzheimer's disease. BMB Reports, 43(10), 704-709.
87. Shinbo, Y.; Niki, T.; Taira, T.; Ooe, H.; Takahashi-Niki, K.; Maita, C.; et al. (2006). Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death and Differentiation, 13(1), 96-108.
88. Singh, U.; Jialal, I. (2006). Oxidative stress and atherosclerosis. Pathophysiology: The Official Journal of the International Society for Pathophysiology/ISP, 13(3), 129-142.
89. Song, J.; Durrin, L. K.; Wilkinson, T. A.; Krontiris, T. G.; Chen, Y. (2004). Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proceedings of the National Academy of Sciences of the United States of America, 101(40), 14373-14378.
90. Spillantini, M. G.; Schmidt, M. L.; Lee, V. M.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839-840.
91. Stankovic-Valentin, N.; Deltour, S.; Seeler, J.; Pinte, S.; Vergoten, G.; Guérardel, C.; et al. (2007). An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Molecular and Cellular Biology, 27(7), 2661-2675.
92. Taira, T.; Saito, Y.; Niki, T.; Iguchi-Ariga, S. M. M.; Takahashi, K.; Ariga, H. (2004). DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Reports, 5(2), 213-218.
93. Takahashi, K.; Ishida, M.; Komano, H.; Takahashi, H. (2008). SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice. Neuroscience Letters, 441(1), 90-93.
94. Tare, M.; Modi, R. M.; Nainaparampil, J. J.; Puli, O. R.; Bedi, S.; Fernandez-Funez, P.; et al. (2011). Activation of JNK signaling mediates amyloid-ß-dependent cell death. PLoS ONE, 6(9), e24361.
95. Trigueros-Motos, L.; Gonzalez, J. M.; Rivera, J.; Andres, V. (2011). Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress. Frontiers in Bioscience (Scholar edition), 3, 1285-1297.
96. Tsutsui, H.; Kinugawa, S.; Matsushima, S. (2011). Oxidative stress and heart failure. American Journal of Physiology. Heart and Circulatory Physiology, 301(6), H2181-H2190.
97. Um, J. W.; Chung, K. C. (2006). Functional modulation of parkin through physical interaction with SUMO-1. Journal of Neuroscience Research, 84(7), 1543-1554.
98. Wang, L.; Banerjee, S. (2004). Differential PIAS3 expression in human malignancy. Oncology Reports, 11(6), 1319-1324.
99. Wang, C.-Y.; Podolsky, R.; She, J.-X. (2006). Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene. Annals of the New York Academy of Sciences, 1079, 257-267.
100. Wang, J.; Wang, Y.; Lu, L. (2012). De-SUMOylation of CCCTC binding factor (CTCF) in hypoxic stress-induced human corneal epithelial cells. The Journal of Biological Chemistry, 287(15), 12469-12479.
101. Wilkinson, K. A.; Henley, J. M. (2010). Mechanisms, regulation and consequences of protein SUMOylation. The Biochemical Journal, 428(2), 133-145.
102. Wislet-Gendebien, S.; D'Souza, C.; Kawarai, T.; St George-Hyslop, P.; Westaway, D.; Fraser, P.; et al. (2006). Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes. The Journal of Biological Chemistry, 281(43), 32148-32155.
103. Xu, Z.; Lam, L. S. M.; Lam, L. H.; Chau, S. F.; Ng, T. B.; Au, S. W. N. (2008). Molecular basis of the redox regulation of SUMO proteases: A protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB journal: Official Publication of the Federation of American Societies for Experimental Biology, 22(1), 127-137.
104. Xu, Y.; Li, J.; Zuo, Y.; Deng, J.; Wang, L.-S.; Chen, G.-Q. (2011). SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors. Cancer Letters, 309(1), 78-84.
105. Yang, D. D.; Kuan, C. Y.; Whitmarsh, A. J.; Rincón, M.; Zheng, T. S.; Davis, R. J.; et al. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature, 389(6653), 865-870.
106. Yang, X.-J.; Seto, E. (2008). Lysine acetylation: codified crosstalk with other posttranslational modifications. Molecular Cell, 31(4), 449-461.
107. Yoshikawa, T.; Toyokuni, S.; Yamamoto, Y.; Naito, Y. (2000). Free radicals in Chemistry, Biology and Medicine (pp. 580). UK: OICA International.
108. Yun, S.-M.; Cho, S.-J.; Song, J. C.; Song, S. Y.; Jo, S. A.; Jo, C.; et al. (2013). SUMO1 modulates Aβ generation via BACE1 accumulation. Neurobiology of Aging, 34(3), 650-662.
109. Zhang, F.; Chen, J. (2008). Leptin protects hippocampal CA1 neurons against ischemic injury. Journal of Neurochemistry, 107(2), 578-587.
110. Zhang, Y.-Q.; Sarge, K. D. (2008). Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochemical and Biophysical Research Communications, 374(4), 673-678.
111. Zhang, F.; Signore, A. P.; Zhou, Z.; Wang, S.; Cao, G.; Chen, J. (2006). Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: Potential signaling mechanisms. Journal of Neuroscience Research, 83(7), 1241-1251.
112. Zhao, J. (2007). Sumoylation regulates diverse biological processes. Cellular and Molecular Life Sciences: CMLS, 64(23), 3017-3033.